Mazdutide has been approved in China (as Moshutai) for weight management and is in Phase III development for other markets. In the Chinese Phase III GLORY-1 trial (610 patients), the 6 mg dose achi...
View full compound profile →Vendors stocking
1
across 1 country
Total listings
1
0 in stock
Price range
£210.00
Stock health
0%
0 vendors · 0 listings
No listings match the current filters. Try adjusting your filters above.
This compound is currently in clinical trials and is not yet approved for commercial sale. Information is for research reference only.
Prices last updated: 15 May 2026
Data sourced from 1 vendor website across 1 country
